Objective: To assess prescribing trends of Fixed dose combination antidiabetics in Diabetes Mellitus patients.
Materials and Methods: An observational, cross-sectional study was carried out in the Medicine OPD of AVBRH, Sawangi(M), Wardha. A total of 500 Diabetes Mellitus Patients were selected for the study after fulfilling the inclusion/exclusion criteria.
Results: Out of 500 patients 484 patients were of type-II DM in whom 5 FDCs were prescribed. Maximum prescribed FDCs were of Metformin and sulfonylurea Metformin + Glimepiride (n=74) and Metformin + Glipizide (n=37). Following FDCs were Metformin + Voglibose (n=52), Glimepiride + Pioglitazone (n=18) and least prescribed was Metformin+ Glimepiride + Voglibose (n=10). All the drugs were prescribed by brand names. Total of 191 patients (39.46%) were prescribed Antidiabetic FDCs.
Conclusion: All Antidiabetic FDCs prescribed were rational. FDCs in Antidiabetics are useful in combination therapy for increasing patient compliance and achieving euglycemia more effectively. .
Cite this article:
Diptendu Santra, Sangita Totade. Prescribing Trends of Antidiabetic Fixed dose combinations in a rural tertiary care teaching hospital in Central India: An Observational, cross-sectional study . Research Journal of Pharmacology and Pharmacodynamics. 2015; 7(1): 19-22. doi: 10.5958/2321-5836.2015.00004.X